Vaxxinova US, Inc.
Records under this name other than the patents Vaxxinova US, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 22 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,109,028 | Compositions produced using enteric pathogens and methods of use Term ended Term ended Nov 17, 2026 · USPTO record | Term ended | Term ended Nov 17, 2026 | USPTO record |
| US 8,025,885 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use Term ended Term ended Aug 28, 2026 · USPTO record | Term ended | Term ended Aug 28, 2026 | USPTO record |
| US 8,007,803 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use Term ended Term ended Aug 2, 2026 · USPTO record | Term ended | Term ended Aug 2, 2026 | USPTO record |
| US 8,119,147 | Compositions produced using enteric pathogens and methods of use Term ended Term ended May 20, 2026 · USPTO record | Term ended | Term ended May 20, 2026 | USPTO record |
| US 8,709,436 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use Term ended Term ended Apr 23, 2026 · USPTO record | Term ended | Term ended Apr 23, 2026 | USPTO record |
| US 8,007,811 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use Term ended Term ended Feb 14, 2026 · USPTO record | Term ended | Term ended Feb 14, 2026 | USPTO record |
| US 8,961,979 | Polypeptides and Immunizing Compositions Containing Gram Positive Polypeptides and Methods of Use Term ended Ended no later than Feb 14, 2026 · Low confidence | Term ended | Ended no later than Feb 14, 2026 | Low confidence |
| US 9,266,944 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use Term ended Ended no later than Feb 14, 2026 · USPTO record | Term ended | Ended no later than Feb 14, 2026 | USPTO record |
| US 9,623,076 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use Term ended Term ended Feb 14, 2026 · USPTO record | Term ended | Term ended Feb 14, 2026 | USPTO record |
| US 9,981,028 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use Term ended Ended no later than Feb 14, 2026 · USPTO record | Term ended | Ended no later than Feb 14, 2026 | USPTO record |